Chemoinformaics analysis of 2,5,9-TRIMETHYLFURO[3,2-G]CHROMEN-7-ONE
| Molecular Weight | 228.247 | nRot | 0 |
| Heavy Atom Molecular Weight | 216.151 | nRig | 7 |
| Exact Molecular Weight | 228.079 | nRing | 3 |
| Solubility: LogS | -2.354 | nHRing | 2 |
| Solubility: LogP | 2.344 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 15 |
| nHA | 3 | APOL | 33.7875 |
| nHD | 0 | BPOL | 16.3785 |
| QED | 0.693 |
| Synth | 2 |
| Natural Product Likeliness | 1.008 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.387 |
| MDCK | 0.0000303 |
| BBB | 0.173 |
| PPB | 0.917667 |
| VDSS | 0.831 |
| FU | 0.0322174 |
| CYP1A2-inh | 0.923 |
| CYP1A2-sub | 0.942 |
| CYP2c19-inh | 0.739 |
| CYP2c19-sub | 0.647 |
| CYP2c9-inh | 0.334 |
| CYP2c9-sub | 0.877 |
| CYP2d6-inh | 0.856 |
| CYP2d6-sub | 0.916 |
| CYP3a4-inh | 0.392 |
| CYP3a4-sub | 0.391 |
| CL | 14.201 |
| T12 | 0.869 |
| hERG | 0.024 |
| Ames | 0.06 |
| ROA | 0.103 |
| SkinSen | 0.821 |
| Carcinogencity | 0.82 |
| EI | 0.978 |
| Respiratory | 0.485 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.647481 |